140 related articles for article (PubMed ID: 37880007)
21. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
[TBL] [Abstract][Full Text] [Related]
22. Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions.
Tsai JH; Cheng CH; Chen CC; Lin YL; Lin LI; Chen ML; Liau JY
Histopathology; 2016 May; 68(6):810-8. PubMed ID: 26496853
[TBL] [Abstract][Full Text] [Related]
23. Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis.
Mezzapesa M; Losurdo G; Celiberto F; Rizzi S; d'Amati A; Piscitelli D; Ierardi E; Di Leo A
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457279
[TBL] [Abstract][Full Text] [Related]
24. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
[TBL] [Abstract][Full Text] [Related]
25. Traditional Serrated Pathway-associated Colorectal Carcinoma: Morphologic Reappraisal of Serrated Morphology, Tumor Budding, and Identification of Frequent PTEN Alterations.
Tsai JH; Jeng YM; Yuan CT; Lin YL; Cheng ML; Liau JY
Am J Surg Pathol; 2019 Aug; 43(8):1042-1051. PubMed ID: 31094930
[TBL] [Abstract][Full Text] [Related]
26. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
[TBL] [Abstract][Full Text] [Related]
27. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological factors associated with BRAF-V600E mutation in colorectal serrated adenomas.
Travaglino A; D'Armiento FP; Cassese G; Campanino MR; Borrelli G; Pignatiello S; Luglio G; Maione F; De Palma GD; D'Armiento M
Histopathology; 2019 Aug; 75(2):160-173. PubMed ID: 30815911
[TBL] [Abstract][Full Text] [Related]
29. Colorectal carcinoma occurring via the adenoma-carcinoma pathway in patients with serrated polyposis syndrome.
Nakamura F; Sato Y; Okamoto K; Fujino Y; Mitsui Y; Kagemoto K; Kawaguchi T; Miyamoto H; Muguruma N; Sonoda T; Tsuneyama K; Takayama T
J Gastroenterol; 2022 Apr; 57(4):286-299. PubMed ID: 35194694
[TBL] [Abstract][Full Text] [Related]
30. SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis.
Tong K; Kothari OA; Haro KS; Panda A; Bandari MM; Carrick JN; Hur JJ; Zhang L; Chan CS; Xing J; Gatza ML; Ganesan S; Verzi MP
Oncogene; 2021 Oct; 40(41):6034-6048. PubMed ID: 34453124
[TBL] [Abstract][Full Text] [Related]
31. Receptor tyrosine kinase fusions act as a significant alternative driver of the serrated pathway in colorectal cancer development.
Chan AW; Pan Y; Tong JH; Lung RW; Kwan JS; Chow C; Tin EK; Chung LY; Li H; Wong SS; Chau SL; Chan YY; Mak TW; Ng SS; To KF
J Pathol; 2020 May; 251(1):74-86. PubMed ID: 32162306
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical Examination is Highly Sensitive and Specific for Detection of the V600E BRAF Mutation in Colorectal Serrated Lesions.
Yamada N; Eizuka M; Sugimoto R; Tanaka Y; Yanagawa N; Yamano H; Suzuki H; Matsumoto T; Sugai T
Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):446-453. PubMed ID: 33306619
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.
Kuan SF; Navina S; Cressman KL; Pai RK
Hum Pathol; 2014 Mar; 45(3):464-72. PubMed ID: 24529329
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological and molecular characterization of deficient mismatch repair colorectal cancer.
Yamada A; Yamamoto Y; Minamiguchi S; Kamada M; Sunami T; Ohashi S; Seno H; Kawada K; Muto M
Hum Pathol; 2022 Dec; 130():1-9. PubMed ID: 36150551
[TBL] [Abstract][Full Text] [Related]
35. CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway.
Rhee YY; Kim KJ; Kang GH
Gut Liver; 2017 Jan; 11(1):38-46. PubMed ID: 27885175
[TBL] [Abstract][Full Text] [Related]
36. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
37. Distinct profile of HIF1α, PTCH, EphB2, or DNA repair protein expression and BRAF mutation in colorectal serrated adenoma.
Morimoto T; Mitomi H; Saito T; Takahashi M; Murakami T; Sakamoto N; Yao T; Watanabe S
J Gastroenterol Hepatol; 2014 Jun; 29(6):1192-9. PubMed ID: 24612059
[TBL] [Abstract][Full Text] [Related]
38. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF
Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V
BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767
[TBL] [Abstract][Full Text] [Related]
39. BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status.
Jang MH; Kim S; Hwang DY; Kim WY; Lim SD; Kim WS; Hwang TS; Han HS
J Korean Med Sci; 2017 Jan; 32(1):38-46. PubMed ID: 27914130
[TBL] [Abstract][Full Text] [Related]
40. Integrated Analysis of the Endoscopic, Pathological and Molecular Characteristics of Colorectal Tumorigenesis.
Suzuki H; Yamamoto E; Yamano HO; Nakase H; Sugai T
Digestion; 2019; 99(1):33-38. PubMed ID: 30554192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
